Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Positive phase III results with AmBisome to be included in NDA filing

Sep. 27, 1996

High clinical efficacy reported for Penederm's Mentax antifungal product

Sep. 27, 1996

Novel antifungal antibiotic reported by German and Swedish researchers

Sep. 27, 1996

Takeda discloses anti-Ureaplasma agents

Sep. 27, 1996

U.S. and Canadian researchers report fungicidal conjugated styryl ketones

Sep. 27, 1996

Bayer claims naphthyridine derivatives

Sep. 27, 1996

Generic cefaclor approved in the U.S.

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Sixteenth approval for Amphotec

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...